Maternal transmission of an Igf2r domain 11: IGF2 binding mutant allele (Igf2rI1565A) results in partial lethality, overgrowth and intestinal adenoma progression

Autor: Francis G. Szele, Susana Frago, Nicholas B. Davies, Mirvat Surakhy, Martin Ducker, Claudia Bühnemann, Matthew P. Crump, Emma J. Carter, Sermet Can, Roman Trikin, A. Bassim Hassan, Jennifer Hughes
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
endocrine system diseases
Placenta
lcsh:Medicine
Receptor
IGF Type 2

Mice
0302 clinical medicine
Loss of Function Mutation
Pregnancy
lcsh:Science
Receptor
Growth Disorders
Multidisciplinary
Homozygote
Imprinting
Intrauterine growth
medicine.anatomical_structure
Disease Progression
Female
Maternal Inheritance
Adenoma
Heterozygote
Mice
Transgenic

Biology
Article
03 medical and health sciences
Genomic Imprinting
Protein Domains
Insulin-Like Growth Factor II
Intestinal Neoplasms
medicine
Gene silencing
Animals
Humans
Binding site
Allele
Cancer models
Alleles
Cell Proliferation
Hyperplasia
lcsh:R
Insulin-like growth factor 2 receptor
Heterozygote advantage
medicine.disease
Embryo
Mammalian

Molecular biology
Disease Models
Animal

030104 developmental biology
HEK293 Cells
lcsh:Q
030217 neurology & neurosurgery
Zdroj: Scientific Reports
Hughes, J, Surakhy, M, Can, S, Ducker, M, Davies, N, Szele, F, Bühnemann, C, Carter, E, Trikin, R, Crump, M P, Frago, S & Hassan, A B 2019, ' Maternal transmission of an Igf2r domain 11 : IGF2 binding mutant allele (Igf2r I1565A ) results in partial lethality, overgrowth and intestinal adenoma progression ', Scientific Reports, vol. 9, no. 1, 11388 . https://doi.org/10.1038/s41598-019-47827-9
Scientific Reports, Vol 9, Iss 1, Pp 1-16 (2019)
ISSN: 2045-2322
Popis: The cation-independent mannose 6-phosphate/insulin-like growth factor-2 receptor (M6P/IGF2R or IGF2R) traffics IGF2 and M6P ligands between pre-lysosomal and extra-cellular compartments. Specific IGF2 and M6P high-affinity binding occurs via domain-11 and domains-3-5-9, respectively. Mammalian maternal Igf2r allele expression exceeds the paternal allele due to imprinting (silencing). Igf2r null-allele maternal transmission results in placenta and heart over-growth and perinatal lethality (>90%) due to raised extra-cellular IGF2 secondary to impaired ligand clearance. It remains unknown if the phenotype is due to either ligand alone, or to both ligands. Here, we evaluate Igf2r specific loss-of-function of the domain-11 IGF2 binding site by replacing isoleucine with alanine in the CD loop (exon 34, I1565A), a mutation also detected in cancers. Igf2rI1565A/+p maternal transmission (heterozygote), resulted in placental and embryonic over-growth with reduced neonatal lethality (80%) observed in homozygotes (Igf2rI1565A/I1565A) suggested that wild-type paternal allele expression attenuates the heterozygote phenotype. To evaluate Igf2r tumour suppressor function, we utilised intestinal adenoma models known to be Igf2 dependent. Bi-allelic Igf2r expression suppressed intestinal adenoma (ApcMin). Igf2rI1565A/+p in a conditional model (Lgr5-Cre, Apcloxp/loxp) resulted in worse survival and increased adenoma proliferation. Growth, survival and intestinal adenoma appear dependent on IGF2R-domain-11 IGF2 binding.
Databáze: OpenAIRE